Applied Finance Capital Management LLC lowered its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 105,413 shares of the conglomerate’s stock after selling 2,553 shares during the quarter. Applied Finance Capital Management LLC’s holdings in Danaher were worth $24,198,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gilbert & Cook Inc. grew its holdings in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. boosted its position in shares of Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after purchasing an additional 43 shares in the last quarter. Dakota Community Bank & Trust NA increased its position in Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares in the last quarter. Howard Capital Management Group LLC boosted its holdings in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares in the last quarter. Finally, Spinnaker Trust grew its stake in shares of Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after acquiring an additional 50 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on DHR. JPMorgan Chase & Co. lowered their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Barclays reduced their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Five research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $278.24.
Insiders Place Their Bets
In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.
Danaher Trading Down 0.6 %
Shares of Danaher stock opened at $180.71 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $129.15 billion, a PE ratio of 34.22, a P/E/G ratio of 2.66 and a beta of 0.86. Danaher Co. has a 1-year low of $171.92 and a 1-year high of $281.70. The company’s fifty day simple moving average is $208.60 and its 200-day simple moving average is $233.05.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. As a group, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.71%. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Using the MarketBeat Dividend Tax Calculator
- Alibaba Caught in Tariff Crossfire: Is It Time to Buy?
- How to Effectively Use the MarketBeat Ratings Screener
- Can Solid Biosciences Challenge Sarepta in the DMD Market?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Will CrowdStrike’s Goodwill Strategy Pay Off in Revenue Gains?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.